Abstract: In patients with head and neck cancer, conventional anatomical magnetic resonance imaging (MRI) scans are commonly used for identification of primary lesion, assessment of structural distortion, and presence of metastatic lymph nodes. However, quantitative analysis of diffusion MRI can provide added value to structural and anatomical evaluation of head and neck tumors (HNT), by differentiation of primary malignant process, prognostic prediction, and treatment monitoring. In this article, we will review the applications of quantitative diffusion MRI in identification of primary malignant tissue, differentiation of tumor pathology, prediction of molecular phenotype, monitoring of treatment response, and evaluation of posttreatment changes in patient with HNT.
Biomedical imaging in head and neck tumors (HNT)
Worldwide, head and neck malignancies account for approximately 4% of the cancer patients, with 550,000 new cases and 380,000 deaths annually, making HNT the sixth most common cancer, globally (1, 2) . In 2016, the global 5-year prevalence rates for cancers of lip and oral cavity, nasopharynx, larynx, and other pharynx were 13.5, 4.4, 8.5, and 6.0 per 100,000, respectively (3) . Notably, the highest age-standardized incidence rate for nasopharyngeal HNT are reported in the Asia-Pacific region, particularly in Indonesia, Micronesia and Eastern Asia, especially Southern China (3) . Greater than 90% of HNT are squamous cell carcinomas (SCC) followed by lymphomas (4) . While radiation therapy and surgical resection can achieve favorable results for early stage head and neck SCC, the odds are less favorable for advanced stages.
Biomedical imaging has a substantial role in diagnosis, and initial staging of HNT, as well as monitoring the treatment response and detection of local recurrence or distant metastasis. Nevertheless, accurate initial risk stratification, and predictive biomarkers of molecular subtypes are needed to improve patient care and pave the road for personalized treatment options in era of precision medicine (5) . Noninvasive imaging biomarkers can play a crucial role in assessment of the entire tumor sample and can be repeated longitudinally to monitor treatment response, and guide decision-making process. This review focuses on the promises of quantitative diffusion MRI in assessment of patients with HNT.
Diffusion weighted imaging (DWI)
D i f f u s i o n M R I c a n a s s e s s c e l l u l a r d e n s i t y a n d cytoarchitecture based on the measurement of water diffusivity. For the purpose of diffusion MRI, two strong opposed gradient pulses are applied along a certain diffusion direction, with the first diffusion-sensitizing gradient dephasing the water molecules, and the second
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Quantitative diffusion magnetic resonance imaging in head and neck tumors gradient completely rephasing the stationary molecules. In living tissues, the motion of water molecules is "restricted" by interactions with other macromolecules, and cell membranes, which is translated into a signal intensity decrease. Such a signal intensity decrease depends on the degree of molecule movement and respective speed along the diffusion-sensitizing gradient, as well as the strength of the gradient itself, and the duration of the diffusionencoding gradients (b-value) (6, 7) . Thus, diffusion abnormalities of water molecules, captured by DWI, can reflect changes of tissue organization and impediments in water molecule motion at a cellular level.
The diffusion-sensitizing effects from the gradients are indicated by the b-value (s/mm 2 ), which represents the duration between gradient pulses that water molecules are allowed to diffuse before the distance is measured (6) . The b-values are defined by the gradient strength, duration, and the time interval between the gradient pulses (8) . Monoand biexponential models can be used for quantifying the diffusion (9) . For monoexponential models, the apparent diffusion coefficient (ADC, expressed in mm 2 /s) is calculated by means of the least-squares fit of signal intensities from images acquired with different b-values, where S(b) and S0 are the signal intensities on images with and without diffusion weighting, respectively, b is the gradient factor in s/mm 2 , and D is the ADC:
However, while fast-moving water molecules quickly lose their phase coherence and signal intensity, even at low b-values, slow-moving molecules will retain high signal intensities far into the higher ranges of b-values (10). Thus, low b-value (0 up to 200 s/mm 2 ) diffusion images reflect microvascularity and tissue perfusion; whereas, high b-value (800 or 1,000 s/mm 2 ) diffusion images represent tissue cellularity (11) . Thus, mono-exponential ADC values cannot separate pure molecular diffusion from motion of water molecules in the capillary network; whereas, multiexponential models using several b-values are more suitable for accurate quantification of diffusion without perfusion contamination (10, 11) . The intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) assess the water molecule diffusivity with multiple b-values. The IVIM can distinguish pure molecular diffusion from motion of water molecules in the capillary network base on low b-value (<200 s/mm 2 ) and high b-value (>200 s/mm 2 ) diffusion image acquisitions (12, 13) . The relationship between signal intensities and multiple b-values can distinguish the real diffusion of water molecules (D) from the contribution of perfusion to the signal decay (D*, pseudodiffusion), and the contribution of perfusion to the diffusion signal (f, vascular volume fraction). For biexponential models, the metrics related to IVIM for each b-value are calculated using (12):
In DKI, multiple b-values are applied to assess the extent to which the diffusion pattern of water molecules deviates from a perfect Gaussian curve that is assumed when calculating monoexponential ADC values (14):
There are limited number of studies examining the optimal combination and number of b-values for IVIM. Lemke et al (30) . The SS-EPI is relatively insensitive to motion but prone to susceptibility artifacts, chemical shift, and geometric distortion, with a limited spatial resolution and relatively thick sections (31) . Compared to SS-EPI, turbo spin echo technique requires longer echo time but less susceptibility artifacts and better spatial resolution (32) . The SS version of turbo spin echo is a diffusion-weighted HASTE sequence with lower sensitivity to motion and susceptibility artifacts as well as geometric distortion compared to the EPI sequence (33) . Overall, the non-echo planar diffusion can improve image quality with lower susceptibility artifacts and higher spatial resolution; however, they non-EPI DWI scans take longer to acquire (which can introduce more motions) and have lower signal-to-noise ratio, which requires multiple averages and prolongs scanning time (11) . Hence, non-echo planar diffusion is usually reserved for problem solving rather than routine clinical practice.
Differentiation of head and neck cancers
Tissue sampling and pathologic examination remain the gold standard for assessing the malignant nature of a head and neck lesion; however, tissue biopsy is not without risk, and cannot examine the whole lesion. Multiple studies have demonstrated the ability and reliability of quantitative diffusion MRI in distinction of benign from malignant lesions and differentiation of different HNT (34) . Although there are many factors affecting the ADC, it is generally accepted that the ADC of a given voxel is inversely proportional to the cellularity of the tissue included in that voxel, and malignant tumors likely demonstrate lower ADC values compared with benign lesions owing to their relatively higher cellularity.
Some authors have focused on distinction of malignant from benign lesions using average ADC values. Using a /s) with a P=0.004 (36) . Quantitative diffusion MRI can also help with differentiation of various histopathologies; for example, differentiation of various salivary gland lesions. Accurate preoperative differentiation of a salivary gland tumor is important in establishing the surgical indication and preoperative planning. Fine needle aspiration cytology, which is currently used for diagnosis of a parotid gland lesion, can achieve 81% to 98% accuracy (37) . While the majority of salivary gland tumors are benign (either pleomorphic adenomas or Warthin tumors), some can be malignant (adenoid cystic carcinoma or mucoepidermoid carcinoma). Prior studies suggest that pleomorphic adenomas (which contain myxoid tissue) have the highest ADC; whereas, Warthin tumors (which contain lymphoid tissue) have the lowest ADC values (38) .
Using a 1. 
Reactive versus metastatic lymphadenopathy
Nodal metastases herald poor prognosis in patients with head and neck cancer, and their detection is important for treatment planning, extent of radiation treatment field, or surgical neck dissection method. Currently, the differentiation of metastatic lymphadenopathy primarily relies on size criteria; however, nonenlarged nodes may harbor malignancy, and reactive nodes may be prominently enlarged (45) . In addition, in patients presenting with suspicious cervical lymphadenopathy, differentiation of lymphoma from metastatic lymph nodes of unknown primary cancer site can be challenging. Distinction of metastatic from lymphomatous lymphadenopathy is particularly crucial since they demand radically different treatment approaches. Quantitative diffusion MRI can help with distinction of these entities. 
Prediction of human papilloma virus (HPV) status
HPV has recently emerged as a major causative risk factor for a subset of oropharyngeal SCC. The HPV-positive oropharyngeal SCC is related to sexual behavior; whereas, HPV-negative cancer is strongly associated with tobacco and alcohol use (51) . The HPV-positive oropharyngeal SCC also has a different biology, and is associated with a better prognosis than HPV-negative SCC (52) . Thus, in the updated eighth edition of the Cancer Staging Manual of the American Joint Committee on Cancer implemented in January 2018, the HPV-positive oropharyngeal SCC is staged separately from HPV-negative type (51) . The classical description of HPV-positive oropharyngeal cancer histology is non-keratinizing and basaloid differentiated SCC as opposed to keratinizing and poorly differentiated form which is commonly seen with HPVnegative forms (52). This histopathological difference has perhaps lent itself to the difference in ADC characteristics of HPV-positive versus HPV-negative oropharyngeal SCC (53) (54) (55) (56) (57) . Recent studies have generally reported a lower mean ADC in primary lesion of HPV-positive oropharyngeal SCC compared to the HPV-negative form ( (61) . These results promise a new role for quantitative diffusion metrics as imaging biomarkers for prediction of molecular biomarkers in patients with HNT. This is particularly important as we move toward application of personalized treatment strategies with chemotherapy agents targeting specific cellular receptors.
Risk stratification and prognostication
Many authors have examined the application of pretreatment ADC quantification for prediction of outcome in patients with head and neck SCC (62) (63) (64) (65) (66) (67) (68) . The majority of these studies suggest that higher pretreatment ADC values in the primary SCC lesion are predictive of poor local control and treatment response ( Histopathological and molecular features such as high stromal content, low cellularity (lower proliferation), micronecrosis and negative HPV status are associated with resistance to treatment and poor outcome in patients with head and neck SCC (54, 55, 73, 74) . These prognostic characteristics are also associated with higher ADC and likely contribute to association of pretreatment high ADC (and D) values with poor outcome in patients with head and neck SCC. In the future, standardized quantitative diffusion MR metrics may be included in prognostic staging schemes of HNT to improve risk stratification and treatment planning.
Treatment response monitoring
After the start of chemotherapy and/or radiation therapy, it is desirable to monitor treatment response, and tailor further therapy to the individual patient. Quantitative diffusion MRI can evaluate the ADC or D value changes during the treatment, and predict therapy response. Notably, King et al. found no correlation between pretreatment ADC parameters with local failure (Table 4) , while primary head and neck SCC with local failure had a lower percentage raise in the mean ADC, higher skewness, and higher kurtosis during treatment, compared with those with local control (67) . The cumulative studies have reported a rise in ADC values of primary head and neck SCC tumors in the first few weeks after the start of treatment (62, 67, 69, 75) . These studies suggest that a smaller percentage rise (<14-25%) in the mean ADC values within the first to third weeks after the therapy initiation is predictive of treatment failure (62, 67, 69, 75, 76 (77) . They could also identify subcategories of HPV-positive head and neck SCC patients with greater sensitivity to radiotherapy (77) . On the other hand, Marzi et al. found that at mid-treatment time point, the patients with regional failure showed significantly higher D values, exhibited larger percent reductions in f, and product D* × f from the baseline (72) . Evaluation of ADC fractional changes in head and neck SCC is promising since the ratio changes could be more reproducible across different scanners and techniques compared to absolute ADC values. However, it should be noted that the optimal timing interval for early intratreatment assessment of ADC values needs to be established given that development of post treatment mature scar tissues may "falsely" decrease ADC in patients with positive response to treatment (7, 78) . In the future prospective trials, serial quantitative assessment of diffusion MRI scans can be applied for close monitoring of treatment response in the early therapy phase and to guide personalized treatment decisions in patients with HNT.
Post treatment changes
Distinction of posttreatment fibrosis and granulation tissue from residual or recurrent tumor can be challenging (79) . Quantitative analysis of diffusion MRI metrics can help distinguish between residual/recurrent malignant tissue and benign posttreatment changes similar to its application for distinction of primary malignant and benign lesions. Prior studies suggest that residual head and neck SCC tends to have lower average ADC compared to benign posttreatment tissue with optimal average ADC threshold of 1.3 to 1.4 ×10 −3 mm 2 /s for distinction of residual tumor (80-82), yielding 71-95.5% accuracy, 45-94.6% sensitivity, and 90-100% specificity ( Table 5 ). These findings are likely reflective of difference in cellularity of malignant tissue compared to fibrotic posttreatment changes. Applying IVIM, Lai et al. compared newly diagnosed nasopharyngeal carcinoma with biopsy-proven postchemoradiation fibrosis (83) . They found that D and f were significantly lower in nasopharyngeal carcinoma than in 
